Indian indices closed lower Tuesday, with investors cautious ahead of the US Federal Reserve’s rate decision. Vedanta, ITC, and Piramal Pharma saw notable price action. Analysts suggest Vedanta and ITC are good long-term buys, while Piramal Pharma shows potential for further upside after a recent correction.
PRISM’s IPO filing mentions Zostel case, CCI investigation
In its UDRHP-I filing to Sebi, the company any ‘adverse’ outcome in legal proceedings involving Zostel may materially and adversely affect its business, reputation, prospects,